Vitrolife AB/Skr VITR
07:00
09:05
11:15
13:20
15:25
1D1W1MYTD1Y5YMAX
About Vitrolife AB
Vitrolife AB is a biotechnology company that operates in the fertility treatment industry, providing products and services designed to support in vitro fertilization (IVF). The company's portfolio includes culture media, IVF disposable devices, and time-lapse systems for embryo assessment. Founded in 1994, Vitrolife has developed a strong presence in the field of reproductive health by focusing on improving clinical results and patient outcomes. Headquartered in Gothenburg, Sweden, the company serves customers globally, with manufacturing facilities and offices across Europe, the Americas, and Asia. Vitrolife's strategic focus on research and development, along with its commitment to quality and innovation, positions it as a significant player in the global IVF market.
Ticker
Skr VITR
Sector
Primary listing
XSTO
Employees
1,103
Headquarters
Gothenburg, Sweden
Website
Vitrolife AB Metrics
BasicAdvanced
kr 12bn
-
-kr 36.80
1.72
kr 1.10
1.26%
Price and volume
Market cap
kr 12bn
Beta
1.72
52-week high
kr 153.50
52-week low
kr 84.00
Average daily volume
210k
Dividend rate
kr 1.10
Financial strength
Current ratio
3.641
Quick ratio
2.76
Long term debt to equity
19.132
Total debt to equity
19.685
Interest coverage (TTM)
9.16%
Profitability
EBITDA (TTM)
988
Gross margin (TTM)
59.23%
Net profit margin (TTM)
-146.99%
Operating margin (TTM)
18.64%
Effective tax rate (TTM)
-2.74%
Revenue per employee (TTM)
kr 3,070,000
Management effectiveness
Return on assets (TTM)
2.81%
Return on equity (TTM)
-46.53%
Valuation
Price to revenue (TTM)
3.489
Price to book
1.45
Price to tangible book (TTM)
-66.56
Price to free cash flow (TTM)
21.865
Free cash flow yield (TTM)
4.57%
Free cash flow per share (TTM)
3.995
Dividend yield (TTM)
1.26%
Forward dividend yield
1.26%
Growth
Revenue change (TTM)
-4.26%
Earnings per share change (TTM)
-1,198.39%
3-year revenue growth (CAGR)
-0.22%
10-year revenue growth (CAGR)
15.97%
3-year earnings per share growth (CAGR)
134.17%
10-year earnings per share growth (CAGR)
35.19%
3-year dividend per share growth (CAGR)
8.97%
10-year dividend per share growth (CAGR)
8.65%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.